Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileRichard T. Lee, M.D.

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressFAS - Harvard
Stem Cell & Regen. Biology
7 Divinity Ave
Cambridge MA 02138
Phone617/768-8282
Fax617/768-8270
vCardDownload vCard (login for email)
Profile Picture
Other Positions
TitleProfessor of Stem Cell and Regenerative Biology
InstitutionFaculty of Arts & Sciences
DepartmentStem Cell and Regenerative Biology


Collapse Overview 
Collapse overview
My research laboratory studies the development of new approaches to cardiovascular diseases by applying fundamentals of molecular biology. The central theme of our laboratory is that merging rigorous molecular biology approaches can yield new approaches to cardiovascular and metabolic diseases. Thus, we work at this interface using techniques in genomics, imaging, physiology, cell biology, and molecular biology. Projects in the laboratory range from stem cell biology, aging, diabetes, and molecular aspects of proteins that participate in diabetes and cardiovascular pathophysiology. For over 9 years, I was Director of the Brigham and Women's Hospital Noninvasive Cardiac Laboratory, where I supervised the training of over 100 clinical and research fellows in echocardiography. I resigned from this position in January, 1999 in order to open my research laboratory, but I maintain an active role in clinical practice and teaching. I have had an outpatient cardiology practice and attend on the inpatient cardiology service at Brigham and Women’s Hospital twice per year. I also teach physical diagnosis to Harvard medical students while volunteering to see patients in a Boston homeless shelter. I enjoy my role as a mentor for both graduate students, research fellows and physician scientists who wish to pursue questions at the interface of molecular biology and molecular medicine. I hope that one of my projects leads to a therapy for patients, but I would be just as happy if one of my students or trainees accomplishes this because they were excited about how science can benefit medicine.


Collapse Mentoring 
Collapse completed student projects
The Effect of Exercise on the Serum Concentrations of a Novel Soluble Receptor and IL-13 Signaling
Summer, 06/09/14 - 08/15/14

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R01DK107396     (LEE, RICHARD T)Sep 1, 2016 - Jun 30, 2021
NIH/NIDDK
Regulation of Fructose Transport by Thioredoxin-Interacting Protein
Role: Principal Investigator

R01HL119230     (LEE, RICHARD T)Jul 1, 2016 - Jun 30, 2020
NIH/NHLBI
Reprogramming Non-myocytes to Cardiomyocytes in vivo
Role: Principal Investigator

R01AG047131     (LEE, RICHARD T)Aug 15, 2015 - Apr 30, 2020
NIH/NIA
A New Pathway for Reversing Cardiac Aging
Role: Principal Investigator

R03AG049657     (LEE, RICHARD T)Apr 15, 2015 - Mar 31, 2017
NIH/NIA
Circulating FSTL3 and Age-related Cardiac Hypertrophy
Role: Principal Investigator

DP3DK101024     (LEE, RICHARD T)Sep 30, 2013 - Aug 31, 2015
NIH/NIDDK
Engineering a Cell-Based Glucose Monitor
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Jay SM, Lee RT. Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair. Circ Res. 2013 Sep 13; 113(7):933-43. PMID: 24030023; PMCID: PMC3868988.
  2. Jay SM, Murthy AC, Hawkins JF, Wortzel JR, Steinhauser ML, Alvarez LM, Gannon J, Macrae CA, Griffith LG, Lee RT. An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential. Circulation. 2013 Jul 9; 128(2):152-61. PMID: 23757312; PMCID: PMC3753575.
  3. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P, Sinha M, Dall'Osso C, Khong D, Shadrach JL, Miller CM, Singer BS, Stewart A, Psychogios N, Gerszten RE, Hartigan AJ, Kim MJ, Serwold T, Wagers AJ, Lee RT. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013 May 9; 153(4):828-39. PMID: 23663781; PMCID: PMC3677132.
  4. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey L, Haas S, Abo R, Tabebordbar M, Lee RT, Burge CB, Boyer LA. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. 2013 Jan 31; 152(3):570-83. PMID: 23352431; PMCID: PMC3563769.
  5. Steinhauser ML, Lee RT. Pericyte progenitors at the crossroads between fibrosis and regeneration. Circ Res. 2013 Jan 18; 112(2):230-2. PMID: 23329790; PMCID: PMC3829001.
  6. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu TD, Guerquin-Kern JL, Lechene CP, Lee RT. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2013 Jan 17; 493(7432):433-6. PMID: 23222518; PMCID: PMC3548046.
  7. Segers VF, Lee RT. Biomaterials to enhance stem cell function in the heart. Circ Res. 2011 Sep 30; 109(8):910-22. PMID: 21960724.
    View in: PubMed
  8. Steinhauser ML, Lee RT. Regeneration of the heart. EMBO Mol Med. 2011 Dec; 3(12):701-12. PMID: 22095736; PMCID: PMC3377117.
  9. Jay SM, Lee RT. Patching up the myocardium. Circ Res. 2011 Aug 19; 109(5):480-1. PMID: 21852553.
    View in: PubMed
  10. Kanki S, Segers VF, Wu W, Kakkar R, Gannon J, Sys SU, Sandrasagra A, Lee RT. Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail. 2011 Jul; 4(4):509-18. PMID: 21606214.
    View in: PubMed
  11. Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011 Apr 8; 8(4):389-98. PMID: 21474103; PMCID: PMC4148018.
  12. Steinhauser ML, Lee RT. Cardiovascular regeneration: pushing and pulling on progenitors. Cell Stem Cell. 2009 Apr 3; 4(4):277-8. PMID: 19341614.
    View in: PubMed
  13. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008 Feb 21; 451(7181):937-42. PMID: 18288183.
    View in: PubMed
  14. Yoshioka J, Imahashi K, Gabel SA, Chutkow WA, Burds AA, Gannon J, Schulze PC, MacGillivray C, London RE, Murphy E, Lee RT. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload. Circ Res. 2007 Dec 7; 101(12):1328-38. PMID: 17916779.
    View in: PubMed
  15. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation. 2007 Oct 9; 116(15):1683-92. PMID: 17875967.
    View in: PubMed
  16. Segers VF, Lee RT. Local delivery of proteins and the use of self-assembling peptides. Drug Discov Today. 2007 Jul; 12(13-14):561-8. PMID: 17631251.
    View in: PubMed
  17. Patwari P, Lee RT. Thioredoxins, mitochondria, and hypertension. Am J Pathol. 2007 Mar; 170(3):805-8. PMID: 17322366; PMCID: PMC1864871.
  18. Hsieh PC, MacGillivray C, Gannon J, Cruz FU, Lee RT. Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation. 2006 Aug 15; 114(7):637-44. PMID: 16894033.
    View in: PubMed
  19. Lindsey ML, Escobar GP, Dobrucki LW, Goshorn DK, Bouges S, Mingoia JT, McClister DM, Su H, Gannon J, MacGillivray C, Lee RT, Sinusas AJ, Spinale FG. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006 Jan; 290(1):H232-9. PMID: 16126817.
    View in: PubMed
  20. Schulze PC, Lee RT. Oxidative stress and atherosclerosis. Curr Atheroscler Rep. 2005 May; 7(3):242-8. PMID: 15811260.
    View in: PubMed
  21. Weinberg EO, Scherrer-Crosbie M, Picard MH, Nasseri BA, MacGillivray C, Gannon J, Lian Q, Bloch KD, Lee RT. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion. Am J Physiol Heart Circ Physiol. 2005 Apr; 288(4):H1802-9. PMID: 15563531.
    View in: PubMed
  22. Yoshioka J, Schulze PC, Cupesi M, Sylvan JD, MacGillivray C, Gannon J, Huang H, Lee RT. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation. 2004 Jun 1; 109(21):2581-6. PMID: 15123525.
    View in: PubMed
  23. Yoshioka J, Lee RT. Cardiovascular genomics. Cardiovasc Pathol. 2003 Sep-Oct; 12(5):249-54. PMID: 14507573.
    View in: PubMed
  24. Lindsey ML, Yoshioka J, MacGillivray C, Muangman S, Gannon J, Verghese A, Aikawa M, Libby P, Krane SM, Lee RT. Effect of a cleavage-resistant collagen mutation on left ventricular remodeling. Circ Res. 2003 Aug 8; 93(3):238-45. PMID: 12855673.
    View in: PubMed
  25. Weinberg EO, Mirotsou M, Gannon J, Dzau VJ, Lee RT, Pratt RE. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics. 2003 Jan 15; 12(2):113-27. PMID: 12454204.
    View in: PubMed
  26. Wang Y, De Keulenaer GW, Weinberg EO, Muangman S, Gualberto A, Landschulz KT, Turi TG, Thompson JF, Lee RT. Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes. Am J Physiol Heart Circ Physiol. 2002 Aug; 283(2):H533-9. PMID: 12124198.
    View in: PubMed
  27. Jay SM, Kurtagic E, Alvarez LM, de Picciotto S, Sanchez E, Hawkins JF, Prince RN, Guerrero Y, Treasure CL, Lee RT, Griffith LG. Engineered bivalent ligands to bias ErbB receptor-mediated signaling and phenotypes. J Biol Chem. 2011 Aug 5; 286(31):27729-40. PMID: 21622572; PMCID: PMC3149363.
  28. Lee RT, Walsh K. The Future of Cardiovascular Regenerative Medicine. Circulation. 2016 Jun 21; 133(25):2618-25. PMID: 27324357.
    View in: PubMed
  29. Steinhauser ML, Bailey AP, Senyo SE, Guillermier C, Perlstein TS, Gould AP, Lee RT, Lechene CP. Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism. Nature. 2012 Jan 15; 481(7382):516-9. PMID: 22246326; PMCID: PMC3267887.
  30. Lindsey ML, Gannon J, Aikawa M, Schoen FJ, Rabkin E, Lopresti-Morrow L, Crawford J, Black S, Libby P, Mitchell PG, Lee RT. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation. 2002 Feb 12; 105(6):753-8. PMID: 11839633.
    View in: PubMed
  31. Kanki S, Jaalouk DE, Lee S, Yu AY, Gannon J, Lee RT. Identification of targeting peptides for ischemic myocardium by in vivo phage display. J Mol Cell Cardiol. 2011 May; 50(5):841-8. PMID: 21316369; PMCID: PMC3075368.
  32. Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, Lee RT. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail. 2009 Nov; 2(6):684-91. PMID: 19919994.
    View in: PubMed
  33. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest. 2006 Jan; 116(1):237-48. PMID: 16357943; PMCID: PMC1312017.
  34. Schmitt JP, Semsarian C, Arad M, Gannon J, Ahmad F, Duffy C, Lee RT, Seidman CE, Seidman JG. Consequences of pressure overload on sarcomere protein mutation-induced hypertrophic cardiomyopathy. Circulation. 2003 Sep 2; 108(9):1133-8. PMID: 12925456.
    View in: PubMed
  35. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, Robbins J, Lee RT. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007 Aug; 13(8):970-4. PMID: 17660827; PMCID: PMC2754571.
  36. Amadi OC, Steinhauser ML, Nishi Y, Chung S, Kamm RD, McMahon AP, Lee RT. A low resistance microfluidic system for the creation of stable concentration gradients in a defined 3D microenvironment. Biomed Microdevices. 2010 Dec; 12(6):1027-41. PMID: 20661647; PMCID: PMC3119200.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For demographic and contact information changes only, HMS/HSDM faculty should contact Human Resources at human_resourceshms.harvard.edu. FAS faculty should contact the Office for Scholarly Communication (oschulmail.harvard.edu) for general questions about Profiles. For data questions, please contact Raelyn Lincoln (raelyn_lincolnharvard.edu) from the FAS Division of Science; Jennifer Shephard (jmshephfas.harvard.edu) from the FAS Division of Social Science; or Alexander Parker (afparkerfas.harvard.edu) from the FAS Division of Arts and Humanities.
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_